Jpmorgan Chase & Co »

Tg Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.6M 267k 17.08
2023-09-30 $1.7M 205k 8.36
2023-06-30 $6.8M 275k 24.84
2023-03-31 $3.5M 235k 15.01
2022-12-31 $3.4M 288k 11.83
2022-06-30 $1.2M 291k 4.25
2022-03-31 $2.6M 269k 9.51
2021-12-31 $5.1M 260k 19.61
2021-03-31 $8.5M 175k 48.20
2020-12-31 $8.3M 160k 52.05
2020-09-30 $4.6M 177k 26.08
2020-06-30 $3.6M 184k 19.49
2020-03-31 $2.0M 205k 9.75
2019-12-31 $2.8M 253k 11.03
2019-09-30 $1.5M 273k 5.62
2019-06-30 $2.1M 258k 8.03
2019-03-31 $2.2M 270k 8.04
2018-12-31 $1.2M 288k 4.04
2018-09-30 $1.7M 305k 5.63
2018-06-30 $3.7M 285k 13.13
2018-03-31 $4.3M 300k 14.20
2017-12-31 $4.6M 560k 8.24
2017-06-30 $3.7M 364k 10.05
2017-03-31 $2.9M 253k 11.65
2016-12-31 $163k 35k 4.64
2016-06-30 $1.0k 157 6.37
2016-03-31 $1.0k 157 6.37
2014-12-31 $13M 798k 15.84
2014-09-30 $17M 1.6M 10.67
2014-06-30 $21M 2.3M 9.39
2014-03-31 $20M 2.8M 6.90
2013-06-30 $73k 12k 6.35